Literature DB >> 12369865

Okadaic acid: the archetypal serine/threonine protein phosphatase inhibitor.

A B Dounay1, C J Forsyth.   

Abstract

As the first recognized member of the "okadaic acid class" of phosphatase inhibitors, the marine natural product okadaic acid is perhaps the most well-known member of a diverse array of secondary metabolites that have emerged as valuable probes for studying the roles of various cellular protein serine/threonine phosphatases. This review provides a historical perspective on the role that okadaic acid has played in stimulating a broad spectrum of modern scientific research as a result of the natural product's ability to bind to and inhibit important classes of protein serine / threonine phosphatases. The relationships between the structure and biological activities of okadaic acid are briefly reviewed, as well as the structural information regarding the particular cellular receptors protein phosphatases 1 (PP1) and 2A. Laboratory syntheses of okadaic acid and its analogs are thoroughly reviewed. Finally, an interpretation of the critical contacts observed between okadaic acid and PP1 by X-ray crystallography is provided, and specific molecular recognition hypotheses that are testable via the synthesis and assay of non-natural analogs of okadaic acid are suggested.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12369865     DOI: 10.2174/0929867023368791

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  39 in total

1.  Roles of fragile X mental retardation protein in dopaminergic stimulation-induced synapse-associated protein synthesis and subsequent alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-4-propionate (AMPA) receptor internalization.

Authors:  Hansen Wang; Susan S Kim; Min Zhuo
Journal:  J Biol Chem       Date:  2010-05-10       Impact factor: 5.157

2.  Overexpression of protein phosphatase 4 correlates with poor prognosis in patients with stage II pancreatic ductal adenocarcinoma.

Authors:  Shaofan Weng; Hua Wang; Weihong Chen; Matthew H Katz; Deyali Chatterjee; Jeffrey E Lee; Peter W Pisters; Henry F Gomez; James L Abbruzzese; Jason B Fleming; Huamin Wang
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-06-04       Impact factor: 4.254

3.  A conserved N-terminal domain mediates required DNA replication activities and phosphorylation of the transcriptional activator IE1 of Autographa californica multicapsid nucleopolyhedrovirus.

Authors:  David J Taggart; Jonathan K Mitchell; Paul D Friesen
Journal:  J Virol       Date:  2012-04-11       Impact factor: 5.103

Review 4.  Marine pharmacology in 2001--2002: marine compounds with anthelmintic, antibacterial, anticoagulant, antidiabetic, antifungal, anti-inflammatory, antimalarial, antiplatelet, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems and other miscellaneous mechanisms of action.

Authors:  Alejandro M S Mayer; Mark T Hamann
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2005 Mar-Apr       Impact factor: 3.228

5.  Crystal structures of protein phosphatase-1 bound to nodularin-R and tautomycin: a novel scaffold for structure-based drug design of serine/threonine phosphatase inhibitors.

Authors:  Matthew S Kelker; Rebecca Page; Wolfgang Peti
Journal:  J Mol Biol       Date:  2008-11-01       Impact factor: 5.469

Review 6.  Targets and effects of yessotoxin, okadaic acid and palytoxin: a differential review.

Authors:  Antonella Franchini; Davide Malagoli; Enzo Ottaviani
Journal:  Mar Drugs       Date:  2010-03-16       Impact factor: 5.118

7.  Androgen receptor phosphorylation and activity are regulated by an association with protein phosphatase 1.

Authors:  Shaoyong Chen; Cristina T Kesler; Bryce M Paschal; Steven P Balk
Journal:  J Biol Chem       Date:  2009-07-21       Impact factor: 5.157

8.  Regulation of the Src homology 2 domain-containing inositol 5'-phosphatase (SHIP1) by the cyclic AMP-dependent protein kinase.

Authors:  Jun Zhang; Scott F Walk; Kodi S Ravichandran; James C Garrison
Journal:  J Biol Chem       Date:  2009-06-03       Impact factor: 5.157

9.  Contribution of natural inhibitors to the understanding of the PI3K/PDK1/PKB pathway in the insulin-mediated intracellular signaling cascade.

Authors:  Jae Youl Cho; Jongsun Park
Journal:  Int J Mol Sci       Date:  2008-11-12       Impact factor: 6.208

Review 10.  Impact of marine drugs on animal reproductive processes.

Authors:  Francesco Silvestre; Elisabetta Tosti
Journal:  Mar Drugs       Date:  2009-11-06       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.